MyDrHank Tirzepatide Review: Starting Prices & Policy Gaps
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
Named tirzepatide product and landing-page starting prices differ; the complete selected payment remains unconfirmed.
Standout details
- Actual named product permits public selection between B-12 and glycine formulations
- Product advertises free consultation and delivery
Things to consider
- Starting headlines do not establish an independently payable monthly charge
- The generic cost FAQ and dose-dependent pricing footnote differ
MyDrHank displays “From $240/mo” on its named compounded-tirzepatide product page. Both the selected B-12 formulation and the separately selected glycine formulation showed that starting label. A different public GLP-1 landing page advertises compounded tirzepatide starting at $200/month. These are different published pathways, not a confirmed identical purchase at two prices.3,4
Compare the named offer and its qualifications
The landing page’s pricing footnote says the final amount depends on medication, dose and treatment plan, is subject to medical eligibility and may change. Neither starting headline establishes the full amount collected, supplied period or continuing renewal charge. Obtain those details for the actual formulation and plan before paying.4
The Ivy Rx review raises the same distinction between a shared GLP-1 starting headline and a selected tirzepatide quote. Compare the named medicine, supplied quantity, full first charge and continuing cost before treating either a category price or an every-dose claim as the complete purchase agreement.6
Its expanded cost FAQ says plans start at $171/month, with no contract, physician review, a personalized treatment plan, prescription medication and free shipping. That is a general program answer: the named $171 cards are semaglutide, while the tirzepatide card says $200. The FAQ also says pricing stays the same at every dose, which conflicts with the dose-dependent pricing footnote. Do not assume a guaranteed flat tirzepatide price.4
MyDrHank: compare the published starting prices
| Published detail | Decision before payment |
|---|---|
| B-12 product selected | From $240/month; full charge and term not established. |
| Glycine product selected | Also from $240/month; not a confirmed all-dose bill. |
| Named tirzepatide landing card | Starting $200/month, subject to dose, plan and eligibility. |
| General cost FAQ | Starts $171/month; not the named tirzepatide card price. |
Get the financial terms before authorizing payment
The product page advertises free consultation and delivery. The landing page says “cancel anytime,” and its FAQ says “no contract.” Those statements do not establish a refund right, renewal-processing deadline or what happens after medical review, prescription preparation or shipment.3,4
The altRX review examines the written subscription and refund conditions behind another cancel-anytime offer. Compare the notice requirement and payment-finality rule, rather than assuming the same slogan produces the same exit rights.
The AbundRx review shows why billing and shipping need separate deadlines: its policy asks for 72 hours before the next bill and separately allows a refund request when an order has not shipped within 14 days. Those are AbundRx’s rules; ask MyDrHank for the cancellation cutoff and shipment remedy attached to its own offer.
The public Terms reviewed do not set out a refund, cancellation, renewal or billing schedule. That limited public information does not establish that every purchase is refundable or that no further agreement applies. Request the agreement for the selected purchase, including any retained consultation charge, nonapproval outcome and treatment of unused paid time.5
MyDrHank: questions before committing
| Published detail | Decision before payment |
|---|---|
| Included-service claims | Product: free consultation/delivery; general FAQ also includes medication. |
| Dose pricing discrepancy | FAQ says flat at every dose; footnote says dose-dependent. |
| Cancellation and refunds | No contract/cancel-anytime claims do not specify a refund or cutoff. |
| Payment and nonapproval | Obtain full charge, future schedule and written declined-treatment outcome. |
Understand the platform and pharmacy roles
The Terms identify Dr. Hank, LLC and say using its platform does not create a provider-patient relationship with Dr. Hank. They describe pharmacy partners generically, with a current list available on request, and do not guarantee a prescription. This does not identify the facility dispensing an individual order or independently establish licensing, accreditation or 503 classification.5
Ask for the actual prescriber, dispensing contact, formulation and supplied quantity. The B-12 and glycine options identify different compounded formulations; their product descriptions do not establish an added clinical benefit for an individual patient. The SURMOUNT trials studied specific products and treatment protocols; their findings do not establish equivalent results for these compounded formulations.1,2
Further reading
AbundRx review · AltRx review · Ascend Vitality review · Compare tirzepatide providers · BMI MD review · Compounded tirzepatide: legal status · Tirzepatide research guide · Gallbladder risks · Thyroid cancer warning · Zepbound side effects
Frequently asked questions
Why does MyDrHank show both $200 and $240 for tirzepatide?
The named product shows from $240/month with either B-12 or glycine selected. A separate landing card starts at $200/month and qualifies pricing by medication, dose, plan and eligibility. The pages do not establish identical purchases or full collected charges.
Is $171 the tirzepatide price, and does every dose cost the same?
The $171 figure is a general FAQ starting price and appears on named semaglutide cards. Tirzepatide starts at $200 on that landing page. Its flat-dose FAQ wording conflicts with a dose-dependent pricing footnote, so confirm the selected plan in writing.
Does cancel anytime mean I receive a refund?
The public marketing does not establish a refund right, renewal cutoff or nonapproval outcome. The reviewed Terms do not state a financial schedule. Obtain the selected-purchase agreement and written cancellation confirmation.
References(6)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- MyDrHank (2026). Compounded tirzepatide: public product and plan options. MyDrHank.
- MyDrHank (2026). Public GLP-1 landing page: starting offer and conditions. MyDrHank.
- MyDrHank (2026). Terms of Use: platform and pharmacy roles. MyDrHank.
- Ivy Rx (2026). Personalized GLP-1 injections: shared starting headline and named ingredients. Ivy Rx.
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsIvy Rx Tirzepatide Review: Starting-Price Limits & Subscription Terms
Separate Ivy Rx’s general $77 GLP-1 headline from a selected tirzepatide quote and compare its recurring subscription and refund-request rules.
ReadaltRX Tirzepatide Review: Monthly Offer & Refund Limits
altRX’s named GLP-1/GIP offer, cancellation deadlines, nonrefundable bundles and unused-service medical-disqualification exception.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadTirzepatide: Evidence, Dosing & Side Effects
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
Read